Collapsed as off-topic by two members at trust level 3 or above
I would be cautious about generalising from the Reading a regulatory notice example above. It is a good example. It is one example.
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
I would be cautious about generalising from the Reading a regulatory notice example above. It is a good example. It is one example.
Adding the measurement that post #30 says would settle it.
Regulatory approval is a decision about a specific product from a specific manufacturer. It does not travel to a different product containing the same molecule.
If this contradicts something upthread, the upthread version may well be the better one.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Why a compound being unapproved is not the same as being illegal to possess
Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about compound…
|
+72 | 78 | 23k | 3mo |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. I was wrong about import rules for personal quantities in a thread last spring…
|
3 | 60k | 12mo | |
|
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…
|
+135 | 163 | 46k | 17mo |
|
What a regulator's shortage notice actually authorises
What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what a regulator's document actually says, since the…
|
+8 | 12 | 15k | 17h |
|
Enforcement priorities versus written rules
Enforcement priorities versus written rules — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of it disagree. I have…
|
2 | 62k | 15mo |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Second pass at: Reimbursement variation across member states
On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement variation across member states that I…
|
+23 | 28 | 45k | 21mo |
|
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
|
+74 | 80 | 7.7k | 18mo |
|
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
|
+46 | 50 | 7.9k | 5mo |
|
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…
|
+124 | 132 | 9.2k | 2mo |
|
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…
|
+135 | 163 | 46k | 17mo |